Dr. Brenda Banwell

Dr. Brenda Banwell is the Chief of the Division of Child Neurology and Professor of Neurology and Pediatrics, Perelman School of Medicine, University of Pennsylvania. Dr. Banwell is the lead investigator of the Canadian Pediatric Demyelinating Disease Program (CPDDP; 5 Principal Investigators, 47 collaborating researchers, 15 site investigators), with co-investigators (Drs. Bar-Or, Arnold, Marrie and Yeh) funded by the Multiple Sclerosis of Canada (2004-2020). Dr. Banwell’s research focuses on the clinical features of MS and related disorders, as well as the neuroimaging, biomarker and outcomes features of children. Dr. Banwell served as the pediatric neurologist on the 2010 and now 2017 International MS Panel on MS Diagnosis (“McDonald criteria”), the International Advisory Committee on Clinical Trials of New Drugs in Multiple Sclerosis, and the National Institute of Health Common Data Elements in MS committee. She is the Director on the Board of the American Academy of Neurology and serves on the Medical Advisory Board for the Multiple Sclerosis Society of Canada and on the Medical Advisory Board of the Multiple Sclerosis International Federation.